Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age-A Bicenter Retrospective Study.

Dominika Śmiałek,Sergiusz Jóźwiak,Katarzyna Kotulska

Journal of clinical medicine（2023）

引用 3|浏览5

暂无评分

摘要

Adverse effects associated with sirolimus use in infants and young children with TSC are frequent yet not life- or health-threatening. Further multicenter prospective clinical trials should determine the long-term safety of sirolimus.

查看译文

关键词

adverse effect,infant,mTOR inhibitor,safety,sirolimus,tuberous sclerosis complex

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要